FDA Approves Tremfya for Active Crohn Disease in Adults
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease
Chronic Conditions and Their Age of Onset Predict Health Trajectory in IBD
Model that incorporated age at diagnosis for each chronic condition developed at 60 years or younger was best performing for premature death
FDA Unveils Transparency Tool for Easy Check of Contaminant Levels in Foods
Tool is an online, searchable database that provides a consolidated list of contaminant levels
Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease
Improved Fibrosis-4 group transitions seen over time for patients with chronic liver disease using statins
Score Can Predict Likelihood of Advanced Colorectal Neoplasia in People Under 45
Model included BMI, first-degree relative family history of CRC, other family history of CRC, tobacco use as factors
Reported Breast, Colorectal Cancer Screening Higher in 2023 Than 2019
Rebounds seen in breast cancer and colonoscopy screening, while reported cervical cancer screening in 2023 remained below 2019 estimates
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
No benefits seen in terms of weight loss, diabetes remission, surgery safety
ASTRO Issues Clinical Guideline for Use of Radiation Therapy in Anal Cancer
For most patients, definitive treatment with combined modality therapy is recommended
Updates Issued for Optimizing Bowel Preparation Quality for Colonoscopy
Use of a split-dose bowel preparation regimen is recommended; same-day regimen acceptable for those undergoing afternoon colonoscopy
Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD
Significantly lower rates of symptom rebound and rebound severity seen four weeks after eradication for those with infection
